Mouse Vascular Endothelial cell Growth Factor D,VEGF-D ELISA kit
-
中文名稱:小鼠血管內(nèi)皮細(xì)胞生長(zhǎng)因子D(VEGF-D)酶聯(lián)免疫試劑盒
-
貨號(hào):CSB-E07357m
-
規(guī)格:96T/48T
-
價(jià)格:¥3200/¥2500
-
其他:
產(chǎn)品詳情
-
產(chǎn)品描述:小鼠血管內(nèi)皮細(xì)胞生長(zhǎng)因子D(VEGF-D)酶聯(lián)免疫試劑盒(CSB-E07357m)為雙抗夾心法ELISA試劑盒,定量檢測(cè)血清、血漿、組織培養(yǎng)上清液、組織勻漿樣本中的Vegfd含量。VEGF-D(血管內(nèi)皮生長(zhǎng)因子D)是一種促進(jìn)血管和淋巴管生成的生長(zhǎng)因子,屬于PDGF/VEGF家族。它在血管生成和淋巴管生成中發(fā)揮重要作用,與腫瘤生長(zhǎng)和轉(zhuǎn)移密切相關(guān)。VEGF-D通過(guò)激活VEGFR-2和VEGFR-3受體,促進(jìn)內(nèi)皮細(xì)胞的增殖、遷移和存活,從而促進(jìn)血管和淋巴管的生成。試劑盒檢測(cè)范圍為0.312 pg/mL-20 pg/mL,該產(chǎn)品可廣泛應(yīng)用于腫瘤生物學(xué)、血管生成機(jī)制、藥物篩選等基礎(chǔ)研究領(lǐng)域,為探索VEGF - D在腫瘤微環(huán)境調(diào)控、血管新生相關(guān)疾病模型中的作用提供可靠的檢測(cè)工具,特別適用于體外培養(yǎng)細(xì)胞模型中生長(zhǎng)因子分泌水平的動(dòng)態(tài)監(jiān)測(cè)及動(dòng)物實(shí)驗(yàn)樣本的批量分析。本品僅用于科研,不用于臨床診斷,產(chǎn)品具體參數(shù)及操作步驟詳見(jiàn)產(chǎn)品說(shuō)明書(shū)。
-
別名:Vegfd ELISA Kit; Figf ELISA Kit; Vascular endothelial growth factor D ELISA Kit; VEGF-D ELISA Kit; c-Fos-induced growth factor ELISA Kit; FIGF ELISA Kit
-
縮寫:FIGF
-
Uniprot No.:
-
種屬:Mus musculus (Mouse)
-
樣本類型:serum, plasma, cell culture supernates, tissue homogenates
-
檢測(cè)范圍:0.312 pg/mL-20 pg/mL
-
靈敏度:0.078 pg/mL
-
反應(yīng)時(shí)間:1-5h
-
樣本體積:50-100ul
-
檢測(cè)波長(zhǎng):450 nm
-
研究領(lǐng)域:Cardiovascular
-
測(cè)定原理:quantitative
-
測(cè)定方法:Sandwich
-
精密度:
Intra-assay Precision (Precision within an assay): CV%<8% Three samples of known concentration were tested twenty times on one plate to assess. Inter-assay Precision (Precision between assays): CV%<10% Three samples of known concentration were tested in twenty assays to assess. -
線性度:
To assess the linearity of the assay, samples were spiked with high concentrations of mouse VEGF-D in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay. Sample Serum(n=4) 1:100 Average % 95 Range % 90-99 1:200 Average % 90 Range % 85-96 1:400 Average % 96 Range % 82-105 1:800 Average % 91 Range % 85-99 -
回收率:
The recovery of mouse VEGF-D spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section. Sample Type Average % Recovery Range Serum (n=5) 90 88-94 EDTA plasma (n=4) 95 89-100 -
標(biāo)準(zhǔn)曲線:
These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed. pg/ml OD1 OD2 Average Corrected 20 2.857 2.705 2.781 2.647 10 2.312 2.239 2.276 2.142 5 1.594 1.531 1.563 1.429 2.5 0.873 0.844 0.859 0.725 1.25 0.550 0.568 0.559 0.425 0.625 0.341 0.344 0.343 0.209 0.312 0.258 0.249 0.254 0.120 0 0.133 0.135 0.134 -
數(shù)據(jù)處理:
-
貨期:3-5 working days
引用文獻(xiàn)
- VEGFD signaling balances stability and activity-dependent structural plasticity of dendrites B Aksan, AK Kenkel, J Yan, J Sánchez Romero,Cellular and Molecular Life Sciences,2024
- Piezo1 regulates meningeal lymphatic vessel drainage and alleviates excessive CSF accumulation D Choi,Nature neuroscience,2024
- Exercise promotes angiogenesis by enhancing endothelial cell fatty acid utilization via liver-derived extracellular vesicle miR-122-5p J Lou,Journal of sport and health science,2021
- Prosiding poster effects of jatropha curcas seed extract to protein level of vegf and histological feature of central vein in liver tissue Nabilah Aulia Hasanuddin.et al,Fakultas Kedokteran dan Ilmu Kesehatan,2016
相關(guān)產(chǎn)品
靶點(diǎn)詳情
-
功能:Growth factor active in angiogenesis, lymphangiogenesis and endothelial cell growth, stimulating their proliferation and migration and also has effects on the permeability of blood vessels. May function in the formation of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. Binds and activates VEGFR-3 (Flt4) receptor.
-
基因功能參考文獻(xiàn):
- lymphangiogenesis is regulated by two distinct proteolytic mechanisms of ligand activation: one in which VEGFC activation by ADAMTS3 and CCBE1 spatially and temporally patterns developing lymphatics, and one in which VEGFD activation by a distinct proteolytic mechanism may be stimulated during inflammatory lymphatic growth PMID: 27159393
- This study uncovers a reciprocal relationship between dendrite geometry, the ability to generate nuclear calcium transients in response to synaptic inputs, and the subsequent induction of expression of plasticity-related and dendritic structure-preserving genes. Insufficient nuclear calcium signaling in CA1 hippocampal neurons and, consequently, reduced expression of the nuclear calcium target gene VEGFD. PMID: 28626015
- Overexpression of VEGFD causes lymphatic hyperplasia in lung, kidney, and brown adipose tissue. Overexpression of VEGFD in white adipose tissue causes a de novo lymphatic network. PMID: 27342876
- Vegf-d promotes oedema in response to hyperoxia in mice and support the hypothesis that VEGF-D signalling promotes vascular leak in human hyperoxic acute lung injury (HALI). PMID: 26924464
- VEGF-D may be beneficial in early-stage tumors since it suppresses the pro-tumorigenic inflammation, while at later stages VEGF-D-induced tumor lymphatics provide a route for metastasis. PMID: 27435926
- These results suggest that lymph node lymphangiogenesis occurs before metastasis in OSCC. VEGF-A and VEGF-D play critical roles in this process. PMID: 26630663
- Results provided evidence that IL-7/IL-7R induce VEGF-D upregulation and promote lymphangiogenesis via c-Fos/c-Jun pathway in lung cancer. PMID: 24115038
- Epidermal keratinocyte proliferation in vitro was not affected by VEGF-C or VEGF-D. PMID: 23695550
- Neutrophils contribute to lymphangiogenesis primarily by modulating VEGF-A bioavailability and bioactivity and, to a lesser extent, secreting VEGF-D. Neutrophils increased VEGF-A bioavailability and bioactivity via the secretion of MMP9 and heparanase. PMID: 24113869
- Vegf-d deficiency alters the caliber of initial lymphatics in the dermis leading to reduced functional capacity. PMID: 23439394
- Vascular endothelial growth factor-C and -D are involved in lymphangiogenesis in mouse unilateral ureteral obstruction. PMID: 22932121
- VEGF-D has a role in progestin-induced break-through bleeding in thin-walled blood and lymphatic endometrial vessels PMID: 22383980
- nuclear calcium-VEGFD signaling mediates the effect of neuronal activity on the maintenance of dendritic arbors in the adult hippocampus and is required for cognitive functioning. PMID: 21745642
- Data show that that OUBC induces profound lymphangiogenesis in the tumor and SLN and substantial lymphatic metastasis to SLN through VEGF-C/D-VEGFR-3 signaling pathway. PMID: 21481239
- VEGF-D over-expression has differential effects on the uterine vasculature. These effects may facilitate VEGF-D's ability to promote endometrial cancer metastasis and disease progression. PMID: 20615255
- We investigated the expression of IEGs, including c-fos, fos-B, c-jun and dusp-1 mRNA, in the mouse heart after a once-daily methamphetamine injection for 1day, 2 or 4weeks. PMID: 19828354
- These results show that VEGF-C/-D together with its receptor VEGFR-3 provides an auto-/paracrine growth and chemotactic system for glial precursors in the developing brain. PMID: 19646499
- there are unique temporal and spatial expressions of VEGF-D isoforms during lung development which related factors have distinct functions in vascular and lymphatic patterning of the lung PMID: 12112468
- VEGF-D promotes tumor angiogenesis, lymphangiogenesis and metastatic spread by a paracrine mechanism PMID: 12148568
- study demonstrated that beta-catenin negative regulation is on theessenger vascular endothelial growth factor-D mRNA 3'-untranslated region PMID: 12920128
- VEGF-C and VEGF-D are ligands for the integrin alpha9beta1 PMID: 15590642
- The lack of a profound lymphatic phenotype in Vegf-d-deficient mice suggests that Vegf-d does not play a major role in lymphatic development. PMID: 15743836
- VEGF-D/VEGFR-3 signaling plays a critical role in osteoblast maturation PMID: 16624815
- results suggest the presence of lymphatic capillaries throughout the skeletal muscle, and present the localisation of VEGF-C and -D in the muscles. PMID: 16924525
- in binding VEGFR-2, furin and PC5 promote cleavage of N-and C-terminal VEGF-D propeptides, whereas PC7 promotes cleavage of the C-terminal propeptide only PMID: 17242158
- Diabetes increased the expression of VEGF-D in skeletal muscle. VEGF-D levels were not changed either in healthy or in diabetic muscle after the exercise training. PMID: 17766486
- The expression of VEGF-D in the marginal portion of tumor significantly associated with lymphatic metastasis and prognosis in patients with pancreatic adenocarcinoma and may induced lymphangiogenesis. PMID: 18061373
- Expression of VEGF-D is involved in growth and lymphatic spread of HCC. Therefore, VEGF-D might represent a therapeutic target in HCC. PMID: 18338756
- These results suggest VEGF-C- and VEGF-D-independent functions for VEGFR-3 in the early embryo. PMID: 18519586
- These data do not support an important role of VEGF-D in (lymph) angiogenesis or in adipose tissue development. PMID: 19022221
- VEGF-C, -D, and -A derived from the CD11b+/Gr-1+ macrophages and local inflamed tissues play a critical role in promoting antigen clearance and inflammation resolution. PMID: 19346498
- Long-term expression of VEGF-C and VEGF-D in skeletal muscle results in the generation of new functional blood and lymphatic vessels. PMID: 19443835
顯示更多
收起更多
-
亞細(xì)胞定位:Secreted.
-
蛋白家族:PDGF/VEGF growth factor family
-
組織特異性:Highly expressed in fetal and adult lung.
-
數(shù)據(jù)庫(kù)鏈接:
Most popular with customers
-
Human Transforming Growth factor β1,TGF-β1 ELISA kit
Detect Range: 23.5 pg/ml-1500 pg/ml
Sensitivity: 5.8 pg/ml
-
-
-
Mouse Tumor necrosis factor α,TNF-α ELISA Kit
Detect Range: 7.8 pg/ml-500 pg/ml
Sensitivity: 1.95 pg/ml
-
-
-
-